0001209191-17-046040.txt : 20170724
0001209191-17-046040.hdr.sgml : 20170724
20170724061513
ACCESSION NUMBER: 0001209191-17-046040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170720
FILED AS OF DATE: 20170724
DATE AS OF CHANGE: 20170724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Sujal
CENTRAL INDEX KEY: 0001588861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17977509
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 3876 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-20
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001588861
Shah Sujal
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BOULEVARD, SUITE 130
NEWARK
CA
94560
1
1
0
0
Interim President & CEO
Common Stock
2017-07-20
4
P
0
891
7.29
A
75891
D
Common Stock
2017-07-20
4
P
0
400
7.30
A
76291
D
Common Stock
2017-07-20
4
P
0
576
7.31
A
76867
D
Common Stock
2017-07-20
4
P
0
100
7.32
A
76967
D
Common Stock
2017-07-20
4
P
0
8033
7.35
A
85000
D
/s/ Sujal Shah
2017-07-24